BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Topics
»
Disease categories and therapies
» Neurology/psychiatric
Neurology/psychiatric
RSS
New 5-HT1D antagonists from SmithKline Beecham
Dec. 4, 1996
McNeil describes new antipsychotic compounds
Dec. 4, 1996
Avonex progresses toward European approval
Dec. 3, 1996
New hope for muscular dystrophy sufferers
Dec. 3, 1996
Antiepileptic drug from Neurogen licensed to Wyeth-Ayerst
Dec. 2, 1996
New anxiolytic under development at Parke-Davis
Dec. 2, 1996
Antiepileptic agent reported by Parke-Davis
Dec. 2, 1996
Ethical's sustained-release morphine sublicensed for Canada
Dec. 2, 1996
CytoTherapeutics and Genentech sign new CNS therapeutics agreement
Nov. 29, 1996
Vertex compound effective in rat model of nerve injury
Nov. 29, 1996
Previous
1
2
…
2963
2964
2965
2966
2967
2968
2969
2970
2971
…
3026
3027
Next
RSS